{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:24:36Z","timestamp":1791109476786,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1093\/carcin\/bgi262","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T01:14:14Z","timestamp":1130980454000},"page":"803-810","source":"Crossref","is-referenced-by-count":36,"title":["NO-donating aspirin induces phase II enzymes in vitro and in vivo"],"prefix":"10.1093","volume":"27","author":[{"given":"Jianjun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Rigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,11,2]]},"reference":[{"key":"key\n\t\t\t\t20171011185618_B1","doi-asserted-by":"crossref","unstructured":"Rigas,B. and Kashfi,K. ( 2004 ) Nitric-oxide-donating NSAIDs as agents for cancer prevention. Trends Mol. Med. , 10 , 324 \u2013330.","DOI":"10.1016\/j.molmed.2004.05.004"},{"key":"key\n\t\t\t\t20171011185618_B2","doi-asserted-by":"crossref","unstructured":"Kashfi,K., Ryan,Y., Qiao,L.L., Williams,J.L., Chen,J., Del Soldato,P., Traganos,F. and Rigas,B. ( 2002 ) Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. J. Pharmacol. Exp. Ther. , 303 , 1273 \u20131282.","DOI":"10.1124\/jpet.102.042754"},{"key":"key\n\t\t\t\t20171011185618_B3","doi-asserted-by":"crossref","unstructured":"Bak,A.W., McKnight,W., Li,P., Del Soldato,P., Calignano,A., Cirino,G. and Wallace,J.L. ( 1998 ) Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sciences , 62 , L367 \u2013L373.","DOI":"10.1016\/S0024-3205(98)00191-X"},{"key":"key\n\t\t\t\t20171011185618_B4","doi-asserted-by":"crossref","unstructured":"Williams,J.L., Kashfi,K., Ouyang,N., del Soldato,P., Kopelovich,L. and Rigas,B. ( 2004 ) NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC( Min\/ +)) mice. Biochem. Biophys. Res. Commun. , 313 , 784 \u2013788.","DOI":"10.1016\/j.bbrc.2003.12.015"},{"key":"key\n\t\t\t\t20171011185618_B5","doi-asserted-by":"crossref","unstructured":"Fiorucci,S., Santucci,L., Gresele,P., Faccino,R.M., Del Soldato,P. and Morelli,A. ( 2003 ) Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology , 124 , 600 \u2013607.","DOI":"10.1053\/gast.2003.50096"},{"key":"key\n\t\t\t\t20171011185618_B6","unstructured":"Iconomou,G., Kalofonos,H.P., Koutras, A.K., Vagenakis,A.G., Rigas,B. and ( 2005 ) A pilot study of no-donating aspirin in patients with pancreatic cancer pain. J. Support Oncol. , in press."},{"key":"key\n\t\t\t\t20171011185618_B7","doi-asserted-by":"crossref","unstructured":"Nath,N., Kashfi,K., Chen,J. and Rigas,B. ( 2003 ) Nitric oxide-donating aspirin inhibits beta-catenin\/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association. Proc. Natl Acad. Sci. USA , 100 , 12584 \u201312589.","DOI":"10.1073\/pnas.2134840100"},{"key":"key\n\t\t\t\t20171011185618_B8","unstructured":"Williams,J.L., Nath,N., Chen,J., Hundley,T.R., Gao,J., Kopelovich,L., Kashfi,K. and Rigas,B. ( 2003 ) Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin\/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention. Cancer Res. , 63 , 7613 \u20137618."},{"key":"key\n\t\t\t\t20171011185618_B9","doi-asserted-by":"crossref","unstructured":"Spiegel,A., Hundley,T.R., Chen,J., Gao,J., Ouyang,N., Liu,X., Go,M.F., Tsioulias,G.J., Kashfi,K. and Rigas,B. ( 2005 ) NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells. Biochem. Pharmacol. , 70 , 993 \u20131000.","DOI":"10.1016\/j.bcp.2005.06.027"},{"key":"key\n\t\t\t\t20171011185618_B10","doi-asserted-by":"crossref","unstructured":"Hundley,T.R. and Rigas,B. ( 2005 ) NO-donating aspirin inhibits colon cancer cell growth via MAP kinase activation. J. Pharmacol. Exp. Ther. , [Epub ahead of print] PMID: 16169935., In press.","DOI":"10.1124\/jpet.105.091363"},{"key":"key\n\t\t\t\t20171011185618_B11","doi-asserted-by":"crossref","unstructured":"Wilkinson,J.t. and Clapper,M.L. ( 1997 ) Detoxication enzymes and chemoprevention. Proc. Soc. Exp. Biol. Med. , 216 , 192 \u2013200.","DOI":"10.3181\/00379727-216-44169"},{"key":"key\n\t\t\t\t20171011185618_B12","doi-asserted-by":"crossref","unstructured":"Kong,A.N., Owuor,E., Yu,R., Hebbar,V., Chen,C., Hu,R. and Mandlekar,S. ( 2001 ) Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE\/EpRE). Drug Metab. Rev. , 33 , 255 \u2013271.","DOI":"10.1081\/DMR-120000652"},{"key":"key\n\t\t\t\t20171011185618_B13","doi-asserted-by":"crossref","unstructured":"Grubben,M.J., Nagengast,F.M., Katan,M.B. and Peters,W.H. ( 2001 ) The glutathione biotransformation system and colorectal cancer risk in humans. Scand J. Gastroenterol. Suppl. , 68 \u201376.","DOI":"10.1080\/003655201753265479"},{"key":"key\n\t\t\t\t20171011185618_B14","doi-asserted-by":"crossref","unstructured":"Sheweita,S.A. and Tilmisany,A.K. ( 2003 ) Cancer and phase II drug-metabolizing enzymes. Curr. Drug Metab. , 4 , 45 \u201358.","DOI":"10.2174\/1389200033336919"},{"key":"key\n\t\t\t\t20171011185618_B15","doi-asserted-by":"crossref","unstructured":"Kwak,M.K., Wakabayashi,N. and Kensler,T.W. ( 2004 ) Chemoprevention through the Keap1\u2013Nrf2 signaling pathway by phase 2 enzyme inducers. Mutat. Res. , 555 , 133 \u201348.","DOI":"10.1016\/j.mrfmmm.2004.06.041"},{"key":"key\n\t\t\t\t20171011185618_B16","doi-asserted-by":"crossref","unstructured":"Lee,J.S. and Surh,Y.J. ( 2005 ) Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. , 224 , 171 \u201384.","DOI":"10.1016\/j.canlet.2004.09.042"},{"key":"key\n\t\t\t\t20171011185618_B17","doi-asserted-by":"crossref","unstructured":"Morimitsu,Y., Nakagawa,Y., Hayashi,K. et al . ( 2002 ) A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J. Biol. Chem. , 277 , 3456 \u201363.","DOI":"10.1074\/jbc.M110244200"},{"key":"key\n\t\t\t\t20171011185618_B18","doi-asserted-by":"crossref","unstructured":"Johnson,D. and Lardy,H. ( 1958 ) Substrate-selective inhibition of mitochondrial oxidations by enhanced tonicity. Nature , 181 , 701 \u2013702.","DOI":"10.1038\/181701a0"},{"key":"key\n\t\t\t\t20171011185618_B19","doi-asserted-by":"crossref","unstructured":"Gamble,M.S. and Cook,G.A. ( 1985 ) Alteration of the apparent Ki of carnitine palmitoyltransferase for malonyl-CoA by the diabetic state and reversal by insulin. J. Biol. Chem. , 260 , 9516 \u20139519.","DOI":"10.1016\/S0021-9258(17)39262-1"},{"key":"key\n\t\t\t\t20171011185618_B20","doi-asserted-by":"crossref","unstructured":"Park,B.C., Liu,Y., Averill,D.R. Jr, Jackman,M.-I. and Rosenberg,D.W. ( 1995 ) Cytochemical localization of the acetone-inducible cytochrome P-450 isoform, CYP2E1, in murine colonic epithelium. Pharmacology , 50 , 339 \u2013347.","DOI":"10.1159\/000139302"},{"key":"key\n\t\t\t\t20171011185618_B21","doi-asserted-by":"crossref","unstructured":"Kashfi,K., McDougall,C.J. and Dannenberg,A.J. ( 1995 ) Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human. Clin. Pharmacol. Ther. , 58 , 625 \u2013630.","DOI":"10.1016\/0009-9236(95)90018-7"},{"key":"key\n\t\t\t\t20171011185618_B22","doi-asserted-by":"crossref","unstructured":"Prochaska,H.J. and Santamaria,A.B. ( 1988 ) Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal. Biochem. , 169 , 328 \u2013336.","DOI":"10.1016\/0003-2697(88)90292-8"},{"key":"key\n\t\t\t\t20171011185618_B23","doi-asserted-by":"crossref","unstructured":"Habig,W.H., Pabst,M.J. and Jakoby,W.B. ( 1974 ) Glutathione S -transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. , 249 , 7130 \u20137139.","DOI":"10.1016\/S0021-9258(19)42083-8"},{"key":"key\n\t\t\t\t20171011185618_B24","doi-asserted-by":"crossref","unstructured":"Richie,J.P. Jr, Skowronski,L., Abraham,P. and Leutzinger,Y. ( 1996 ) Blood glutathione concentrations in a large-scale human study. Clin. Chem. , 42 , 64 \u201370.","DOI":"10.1093\/clinchem\/42.1.64"},{"key":"key\n\t\t\t\t20171011185618_B25","doi-asserted-by":"crossref","unstructured":"Prochaska,H.J., Santamaria,A.B. and Talalay,P. ( 1992 ) Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl Acad. Sci. USA , 89 , 2394 \u20132398.","DOI":"10.1073\/pnas.89.6.2394"},{"key":"key\n\t\t\t\t20171011185618_B26","unstructured":"Beaumont,P.O., Moore,M.J., Ahmad,K., Payne,M.M., Lee,C. and Riddick,D.S. ( 1998 ) Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin. Cancer Res. , 58 , 947 \u2013955."},{"key":"key\n\t\t\t\t20171011185618_B27","unstructured":"O'Dwyer,P.J., Yao,K.S., Ford,P., Godwin,A.K. and Clayton,M. ( 1994 ) Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. Cancer Res. , 54 , 3082 \u20133087."},{"key":"key\n\t\t\t\t20171011185618_B28","doi-asserted-by":"crossref","unstructured":"Meister,A. ( 1991 ) Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. , 51 , 155 \u2013194.","DOI":"10.1016\/0163-7258(91)90076-X"},{"key":"key\n\t\t\t\t20171011185618_B29","doi-asserted-by":"crossref","unstructured":"Dhakshinamoorthy,S. and Porter,A.G. ( 2004 ) Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J. Biol. Chem. , 279 , 20096 \u201320107.","DOI":"10.1074\/jbc.M312492200"},{"key":"key\n\t\t\t\t20171011185618_B30","doi-asserted-by":"crossref","unstructured":"Hess,D.T., Matsumoto,A., Kim,S.O., Marshall,H.E. and Stamler,J.S. ( 2005 ) Protein S -nitrosylation: purview and parameters. Nat. Rev. Mol. Cell. Biol. , 6 , 150 \u2013166.","DOI":"10.1038\/nrm1569"},{"key":"key\n\t\t\t\t20171011185618_B31","doi-asserted-by":"crossref","unstructured":"Rayyan,Y., Williams,J. and Rigas,B. ( 2002 ) The role of NSAIDs in the prevention of colon cancer. Cancer Invest. , 20 , 1002 \u20131011.","DOI":"10.1081\/CNV-120005917"},{"key":"key\n\t\t\t\t20171011185618_B32","doi-asserted-by":"crossref","unstructured":"Tew,K.D., O'Brien,M., Laing,N.M. and Shen,H. ( 1998 ) Coordinate changes in expression of protective genes in drug-resistant cells. Chem. Biol. Interact. , 111\u2013112 , 199 \u2013211.","DOI":"10.1016\/S0009-2797(97)00162-2"},{"key":"key\n\t\t\t\t20171011185618_B33","doi-asserted-by":"crossref","unstructured":"Smitskamp-Wilms,E., Hendriks,H.R. and Peters,G.J. ( 1996 ) Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9. Gen. Pharmacol. , 27 , 421 \u2013429.","DOI":"10.1016\/0306-3623(95)00118-2"},{"key":"key\n\t\t\t\t20171011185618_B34","unstructured":"Begleiter,A., Leith,M.K., Curphey,T.J. and Doherty,G.P. ( 1997 ) Induction of DT-diaphorase in cancer chemoprevention and chemotherapy. Oncol. Res. , 9 , 371 \u2013382."},{"key":"key\n\t\t\t\t20171011185618_B35","unstructured":"Winski,S.L., Hargreaves,R.H., Butler,J. and Ross,D. ( 1998 ) A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin. Cancer Res. , 4 , 3083 \u20133088."},{"key":"key\n\t\t\t\t20171011185618_B36","doi-asserted-by":"crossref","unstructured":"Kitamura,S., Terada,A., Kamio,H., Sugihara,K., Koga,N. and Ohta,S. ( 1999 ) DT-diaphorase-like quinone reductase in rat plasma. Biol. Pharm. Bull. , 22 , 883 \u2013885.","DOI":"10.1248\/bpb.22.883"},{"key":"key\n\t\t\t\t20171011185618_B37","doi-asserted-by":"crossref","unstructured":"Kashfi,K., Borgo,S., Williams,J.L., Chen,J., Gao,J., Glekas,A., Benedini,F., Del Soldato,P. and Rigas,B. ( 2005 ) Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo . J. Pharmacol. Exp. Ther. , 312 , 978 \u2013988.","DOI":"10.1124\/jpet.104.075994"},{"key":"key\n\t\t\t\t20171011185618_B38","doi-asserted-by":"crossref","unstructured":"Gao,J., Kashfi,K. and Rigas,B. ( 2005 ) In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism. J. Pharmacol. Exp. Ther. , 312 , 989 \u2013997.","DOI":"10.1124\/jpet.104.076190"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/27\/4\/803\/7090119\/bgi262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T02:43:50Z","timestamp":1626662630000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/carcin\/article\/27\/4\/803\/2390972\/NOdonating-aspirin-induces-phase-II-enzymes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,2]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,11,2]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgi262","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,4]]},"published":{"date-parts":[[2005,11,2]]}}}